FDA Denies Petition Recommending CoQ10/Statin Use, Draws Lawsuit
This article was originally published in The Tan Sheet
Executive Summary
Supplement industry stakeholders claim FDA is putting statin patients at risk by not requiring labeling that would recommend users of the cholesterol-lowering drugs take supplemental CoQ10